| 我的感觉是 双 | | | | | | | 清镜入关键词 | | | 2025年5月11日 星期日 O 型染 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | | △ 单报投诉 | | 网站首页 | 法院概况 | | 法院新闻 | | 诉讼服务 | | 审务公开 | 执行信息 | | 权威发布 | | △ 当前位置: 首页>法院公告 > 开庭公告 | | | | | | | | | | | | 法院公告 | 开庭公告 | | | | | | | | | | | + 开庭公告 | | 法院; 全部 | | | 4 | 品血Y: | 浙江东方基因生物制品股份 | 搜 索 | | | | ▶ 减刑假释 | 品展 | 19.000 | 开盘日期 | 排期日期 | ж号 | ਡਰ | 审判长/主审人 | 公语人/重告/上 诉人/申请人 | 被告/被告人/被上诉 人/被申请人 | | | ▶ 破产公告 | 湖州市中 极人民法 R | 第十一选 B | 2025-05-15 0 9:00:0 ...

Core Viewpoint - FS Medical Supplies, LLC has filed a lawsuit against Zhejiang Oriental Gene Biological Products Co., Ltd. and its subsidiary, claiming breach of contract regarding a "no circumvention" clause related to COVID-19 testing kits [2][4]. Group 1: Lawsuit Details - The lawsuit was filed in the U.S. District Court for the Southern District of Texas, with the case number 4:25-CV-1332, and the cause of action is a contract dispute [4][6]. - The plaintiff alleges that the defendants violated the "no circumvention" clause by directly providing COVID-19 testing kits to FS Medical Supplies' customers, resulting in economic losses for the plaintiff [4][5]. - The plaintiff is seeking damages that include a penalty of no less than $1 billion, along with compensatory damages of at least $250 million, and other legal costs [6][7]. Group 2: Company Response and Impact - The company has engaged U.S. legal counsel to analyze the lawsuit's validity and intends to actively respond to the claims, asserting that the plaintiff's breach of contract claims are unfounded [7]. - The company has also initiated legal action against FS Medical Supplies in China, claiming that the framework agreement is invalid due to the plaintiff's lack of medical device operating licenses and false representations [7]. - Currently, the company's operations remain normal, and there are no frozen or restricted assets, indicating that the lawsuit will not impact the company's financial results for 2024, although future impacts remain uncertain [2][7].